Top compounds associated with response to SRF


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.08
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.067 0.08
mRNA ouabain CTRPv2 pan-cancer AAC 0.063 0.08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.08
mRNA LE-135 CTRPv2 pan-cancer AAC 0.066 0.08
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.065 0.08
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.08
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.09
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.061 0.09
mRNA GW843682X CTRPv2 pan-cancer AAC 0.061 0.09
Download CSV